Run time: 83m

  0      0

2019 AABB Annual Meeting On-Demand


SN5-34: Research and Progress (RAP) Session: The Role of Viscoelastic Testing in Bleeding Patients: Precision Transfusion Therapy, Imprecision at its Finest, or Somewhere in Between?


Oct 20, 2019 4:00pm ‐ Oct 20, 2019 5:30pm

Expiration Date: Dec 31, 2021


Credits: None available.

Standard: $25.00
Members: $20.00

Description

While objective laboratory data is regularly utilized to guide transfusion practices, it is often unclear which data points are relevant when considering whether a patient requires plasma, platelet and/or cryoprecipitate transfusions. In this session, Dr. Wool will provide a background on viscoelastic testing and which contexts this testing is being applied to guide transfusion practices. Drs. John Hess and Melissa Cushing will then present conflicting viewpoints on whether viscoelastic testing is useful in guiding transfusion practices. After the formal presentations, an informal discussion will occur amongst the panel presenters and the audience to explore different viewpoints on the topic

Learning Objectives:
  • Explain the background on viscoelastic testing.
  • List pros and cons for using viscoelastic assays.
  • Debate the utility of viscoelastic testing in guiding transfusion practices.

Speaker(s):

  • Dr. Melissa M. Cushing, MD, Weill Cornell Medicine Department of Pathology and Laboratory Medicine
  • Prof. John R. Hess, MD, Division of Transfusion Medicine, University of Washington
  • Dr. Ravi Sarode, MD, Co-Editor-in-Chief, "Transfusion and Apheresis Science” Journal, John H. Childers, MD, Professorship in Pathology, Professor (Tenure) of Pathology and Internal Medicine (Hematology/Oncology), Chief of Pathology and Medical Director, UTSW Clinical Laborato, UT Southwestern Medical Center, Department of Pathology, Division of Transfusion Medicine and Hemostasis
  • Geoffrey Wool, MD, PHD, Medical Director, Coagulation Laboratory, Attending, Transfusion Medicine/Apheresis Service, University of Chicago

Disclosures

  • Melissa Cushing, MD :

    Cerus: Consultant, Grant/Research Support (Secondary Investigators need not disclose)  I  Octapharma: Consultant

  • John Hess, MD :

    Hemerus, LLC: Consultant  I  gel-e Life Sciences: Stock Shareholder (self-managed)  I  Up-To-Date: Honoraria

  • Ravi Sarode, MD :

    Nothing to Disclose

  • Geoffrey Wool, MD, PHD :

    Diagnostica Stago: Consultant, Speaker's Bureau, Honoraria

Credits Available


SN5-34: Research and Progress (RAP) Session: The Role of Viscoelastic Testing in Bleeding Patients: Precision Transfusion Therapy, Imprecision at its Finest, or Somewhere in Between? Evaluation

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content